Adaptive Biotechnologies(ADPT)
Search documents
Adaptive Biotechnologies(ADPT) - 2019 Q4 - Annual Report
2020-02-26 21:53
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-38957 ADAPTIVE BIOTECHNOLOGIES CORPORATION (Exact Name of Registrant as Specified in its Charter) Washington 27-0907024 (St ...
Adaptive Biotechnologies(ADPT) - 2019 Q3 - Earnings Call Transcript
2019-11-13 03:55
Adaptive Biotechnologies Corp (NASDAQ:ADPT) Q3 2019 Earnings Conference Call November 12, 2019 4:30 PM ET Company Participants Carrie Mendivil - IR Chad Robins - CEO & Co-Founder Julie Rubinstein - President Chad Cohen - CFO Harlan Robins - Chief Scientific Officer & Co-Founder Conference Call Participants Tycho Peterson - JPMorgan Derik De Bruin - Bank of America Merrill Lynch Brian Weinstein - William Blair David Westenberg - Guggenheim Securities Amanda Murphy - BTIG Operator Good afternoon, ladies and g ...
Adaptive Biotechnologies(ADPT) - 2019 Q3 - Quarterly Report
2019-11-12 21:40
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-38957 ADAPTIVE BIOTECHNOLOGIES COR ...
Adaptive Biotechnologies(ADPT) - 2019 Q2 - Earnings Call Transcript
2019-08-14 10:45
Adaptive Biotechnologies Corp (NASDAQ:ADPT) Q2 2019 Earnings Conference Call August 13, 2019 4:30 PM ET Company Participants Carrie Mendivil - IR Chad Robins - CEO & Co-founder Julie Rubinstein - President Harlan Robins - Chief Scientific Officer & Co-Founder Chad Cohen - CFO Conference Call Participants Patrick Donnelly - Goldman Sachs Tycho Peterson - JPMorgan Derik De Bruin - Bank of America Merrill Lynch Doug Schenkel - Cowen Brian Weinstein - William Blair Dave Westenberg - Guggenheim Securities Amanda ...
Adaptive Biotechnologies(ADPT) - 2019 Q2 - Quarterly Report
2019-08-13 20:36
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-38957 ADAPTIVE BIOTECHNOLOGIES CORPORATION (Exact Name of Registrant as Specified in its Charter) Washington 27-0907024 ...